Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors

A compound of formula (I),

• wherein
• R is selected from the group consisting of
• R1 is selected from the group consisting of H and F;
• the moiety =A1-CR=A2- is selected from the group consisting of ═N—CR═N—, ═N—CR═CH— and ═CH—CR═N—;
• and
• the moiety -L1=L2- is selected from the group consisting of —N═N—, —N═CH— and —CH═N—;
• and/or its tautomers
• or a pharmaceutically acceptable salt thereof.